Australia markets closed

Esperion Therapeutics Inc (0ET.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
2.3750+0.0200 (+0.85%)
At close: 06:30PM CET
Full screen
Previous close2.3550
Bid2.3950 x 150000
Ask2.4400 x 150000
Day's range2.3450 - 2.3750
52-week range0.6660 - 6.1920
Avg. volume226
Market capN/A
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings date27 Feb 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

    ANN ARBOR, Mich., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that, on February 13, 2024, the Company granted 66 new employees 204,900 restricted stock units (RSUs) under Esperion’s 2017 Inducement Equity Incentive Plan. The 2017 Inducement Equity Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Esperion (or following a bona fide period of non-employment), as an inducemen

  • Insider Monkey

    Should You Sell Esperion Therapeutics (ESPR)?

    Tourlite Capital Management, an investment management firm, released its fourth quarter 2023 investor letter, a copy of which can be downloaded here. Tourlite Fund, LP Founder Class returned 1.1% for Q4 2023 and 8.8% for the year. Since its inception in April 2022, the fund returned 14.3% compared to 8.4%, and 0.5% returns for the S&P […]

  • Zacks

    Esperion Therapeutics (ESPR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

    Esperion Therapeutics (ESPR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.